UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934


                         Date of Report: April 14, 2005
                        --------------------------------
                        (Date of earliest event reported)


                              OSK CAPITAL III CORP.
                      ------------------------------------
             (Exact name of registrant as specified in its charter)


        COLORADO                  000-30023                     84-1491676
    --------------               -----------             ---------------------
        State of                 Commission                   IRS Employer
     incorporation               File Number             Identification Number


                               1 Place Ville-Marie
                                   Suite 2821
                                  Montreal, Qc
                                     H3B 4R4
             -------------------------------------------------------
                    (Address of principal executive offices)


                                Tel: 514-448-6710
                              --------------------
                           (Issuer's telephone number)


                      P. O. Box 461029, Glendale, CO 80220
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


Copies of all communications, including all communications sent to the agent for
service

Copies of all communications, including all communications sent to the agent for
service, should be sent to:

                              Joseph I. Emas, Esq.
                                 Attorney at Law
                             1224 Washington Avenue
                              Miami Beach, FL 33139

<PAGE>

SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

The Company was  incorporated  under the laws of the State of Nevada on March 2,
1999, and is in the early  developmental  and promotional  stages.  To date, the
Company's only activities have been organizational  ones, directed at developing
its business plan and raising its initial capital. The Company has not commenced
any commercial operations.

On March 15, 2004, Frank Kramer and Deborah Salerno have resigned as officers of
OSK  CAPITAL  III  CORP.  and have  also  resigned  as  members  of the Board of
Directors of OSK CAPITAL III CORP. Further to the resignation of Ms. Salerno and
Mr. Kramer,  Francis Mailhot remains the sole director and has been nominated as
President and CEO of the Company.

On March 14, 2005, OSK CAPITAL III ("OSC"), a Nevada corporation,  completed the
acquisition of Ideal Medical Inc., a Texas corporation, pursuant to an Agreement
and Plan of Merger,  the form of which is attached as Exhibit 2.1 hereto whereby
OSC to exchanged shares of OSC for one hundred percent (100%) of the outstanding
shares of Ideal Medical,  Inc. d/b/a Integrated  Medical  Solutions  ("IMS"),  a
Texas corporation.  At the effective time of the merger,  Ideal Medical Inc. was
merged with and into our wholly  owned  subsidiary,  OSK  Acquisition  Corp.,  a
Florida  corporation,  which will be subsequently  dissolved and merged into the
Company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

Management of OSK Capital III Corp.  intend to request a name change  Integrated
Medical  Solutions  Inc. to better  reflect the  acquired  business  and general
business model.

SECTION 2 - FINANCIAL INFORMATION

ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

On March 14, 2005, the company  completed the acquisition of Ideal Medical Inc.,
a Texas  corporation,  pursuant to an Agreement and Plan of Merger,  the form of
which is attached as Exhibit 2.1 hereto.  At the  effective  time of the merger,
Ideal Medical Inc. will be merged with and into our wholly owned subsidiary, OSK
Acquisition Corp., a Florida corporation,  which will be subsequently  dissolved
and merged into the company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

<PAGE>

SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT

ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT.

Pursuant to the completion of the reverse merger  transaction on March 30, 2005,
a change  of  control  occurred.  The  table  below  outlines  the  shareholders
representing Officers,  Directors,  Control and or Affiliates and the percentage
owned by them post reverse merger.

<TABLE>
<CAPTION>
        ---------------------------------------------------- ------------------- --------------
        NAME OF SHAREHOLDER                                   NUMBER OF SHARES     PERCENTAGE
                                                                   OWNED
        ---------------------------------------------------- ------------------- --------------
<S>                                                              <C>                  <C>
        Angela Buffa (1)                                         16,000,000           67.5%
        ---------------------------------------------------- ------------------- --------------
        Mawe Investments  (2)                                    4,000,000            16.9%
        ---------------------------------------------------- ------------------- --------------
        Les Services Financiers Francis Mailhot Inc. (3)          268,668              1%
        ---------------------------------------------------- ------------------- --------------
        Toyma Capital Inc. (4)                                    394,918              2%
        ---------------------------------------------------- ------------------- --------------
        9088-0909 Quebec Inc. (5)                                  73,250             0.03%
        ---------------------------------------------------- ------------------- --------------
        Marie-France Giguere (6)                                   30,000             0.01%
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES HELD BY DIRECTORS, OFFICER, CONTROL         20,766,836            88%
        AND OR AFFILIATES
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES HELD BY PUBLIC (7)                          2,933,164             12%
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES OUTSTANDING (8)                             23,700,000           100%
        ---------------------------------------------------- ------------------- --------------
        Warrants (9)                                                 0
        ---------------------------------------------------- ------------------- --------------
        Options (10)                                               80,000
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES OUTSTANDING ON A FULLY DILUTED BASIS        23,780,000
        ---------------------------------------------------- ------------------- --------------
</TABLE>

1)       Angela Buffa is the Issuer's  Chairman and Chief  Executive  Officer
2)       Mawe Investments is a company 100% owned and controlled by Louisa Santo
3)       Les Services  Financiers  Francis  Mailhot Inc. Is a company 100% owned
         and controlled by Francis  Mailhot and Francis Mailhot is a director of
         the issuer and is a managing  director at Finkelstein  Capital Inc. and
         Finkelstein Capital Inc. is a corporate finance advisory firm presently
         retained by the Issuer.  Les Services  Financiers  Francis Mailhot Inc.
         owns 25% of Finkelstein Capital Inc.
4)       Toyma Capital Inc. is a company 100% owned by the Amyot Family Trust of
         which Mr.  Jean-Francois Amyot is one of the beneficiaries of the trust
         and Mr. Amyot is a managing  director of  Finkelstein  Capital Inc. and
         Finkelstein Capital Inc. is a corporate finance advisory firm presently
         retained by the Issuer.  Toyma  Capital  Inc.  owns 25% of  Finkelstein
         Capital Inc.
5)       9088-0909  Quebec Inc. is a company 100% owned by Marie-France  Giguere
         who is the common law spouse of Francis  Mailhot,  one of the  Issuer's
         Director.
6)       Marie-France  Giguere is the common law spouse of Francis Mailhot,  one
         of the Issuer's Director.
7)       There  are  2,933,164  held  by the  public,  of  which  1,102,000  are
         registered and 1,831,164 are restricted.
8)       There are total of 23,700,000 shares  outstanding held by a total of 64
         shareholders.
9)       No warrants have been issued
10)      In 2004, Roger Morlan received 30,000 options  exercisable on or before
         January 2, 2007 at a strike price of $0.50,  also in 2004, Myra Batista
         received  20,000 options  exercisable on or before January 2, 2007 at a
         strike price of $0.50,  In 2003,  Roger Morlan  received 20,000 options
         exercisable  on or before  January 2, 2006 at a strike  price of $0.30,
         also in 2003, Myra Batista  received  10,000 options  exercisable on or
         before January 2, 2006 at a strike price of $0.30.

<PAGE>

ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL  OFFICERS;  ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.

Pursuant  to  the  reverse  merger  transaction,   the  following  Election  and
nomination took place on March 30, 2005.

ANGELA BUFFA, Chairman, President

Angela  Buffa has been the  Chairman of the Board  since  1989.  She founded the
Company as a diagnostic imaging equipment and commodities supplier after serving
as a  national  sales  manager  and  general  manager  for two major  healthcare
companies.  As the Chief Executive  Officer,  she has directed and  administered
hundreds of healthcare,  construction and government projects across the country
during the last sixteen years. Under her leadership, Ideal Medical Systems, Inc.
was the  recipient in 2001 of the  "Emerging  Top Ten  Businesses"  award by the
Houston  Business  Council.  During the last two years,  Ms. Buffa has developed
innovative  proprietary  RFID  technologies  that  bring  new  solutions  to the
healthcare industry's challenges.  She has business training from Dartmouth Amos
Tuck School of Business  Administration,  University of Texas Advanced Executive
Program,  and Clark  University.  She has also served as moderator  and industry
expert at numerous  healthcare  conferences  and small business  venture capital
seminars.

ROGER MORLAN, Director

Roger W. Morlan has been a director since August 1999.  Since February 1993, Mr.
Morlan has been the Chief Executive Officer of Cobb Real Estate Construction and
Development,  Inc. based in Atlanta, Georgia. Prior to starting Cobb, Mr. Morlan
was a Project Manager for Senco  Products,  Inc., a major  manufacturer  for the
construction  industry,  a firm  which he  joined in 2002.  Prior to Senco,  Mr.
Morlan was the  Director  of  Marketing  for Ideal  Medical,  Inc.  where he was
responsible  for  establishing   relationships  with  leading  Group  Purchasing
Organizations  (GPOs).  Mr. Morlan has a B.A. in International  Economic Affairs
with a minor in Management from the State University of West Georgia.

MYRA BATISTA, Director

Myra Batista has been a director since January 2001.  From 1998, Ms. Batista has
been the Manager of  Occupational  Therapy at  Palmetto  General  Hospital  with
responsibilities  that include managing the durable medical equipment program at
one of the largest  hospitals in Florida.  Ms.  Batista has been a consultant to
various  companies  with a focus on managing and  maximizing  the usage of their
medical  equipment  inventory.  Ms.  Batista has a B.S.  degree in  Occupational
Therapy from Florida  International  University with certifications on Automated
External Defibrillator and on Ultrasound Equipment.


ITEM 7.01 REGULATION FD DISCLOSURE.

The Company was  incorporated  under the laws of the State of Nevada on March 2,
1999, and is in the early  developmental  and promotional  stages.  To date, the
Company's only activities have been organizational  ones, directed at developing
its business plan and raising its initial capital. The Company has not commenced
any commercial operations.

On March 15, 2004, Frank Kramer and Deborah Salerno have resigned as officers of
OSK  CAPITAL  III  CORP.  and have  also  resigned  as  members  of the Board of
Directors of OSK CAPITAL III CORP. Further to the resignation of Ms. Salerno and
Mr. Kramer,  Francis Mailhot remains the sole director and has been nominated as
President and CEO of the Company.

On March 14, 2005, OSK CAPITAL III ("OSC"), a Nevada corporation,  completed the
acquisition of Ideal Medical Inc., a Texas corporation, pursuant to an Agreement
and Plan of Merger,  the form of which is attached as Exhibit 2.1 hereto whereby
OSC to exchanged shares of OSC for one hundred percent (100%) of the outstanding

<PAGE>

shares of Ideal Medical,  Inc. d/b/a Integrated  Medical  Solutions  ("IMS"),  a
Texas corporation.  At the effective time of the merger,  Ideal Medical Inc. was
merged with and into our wholly  owned  subsidiary,  OSK  Acquisition  Corp.,  a
Florida  corporation,  which will be subsequently  dissolved and merged into the
Company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

Management  of OSK  Capital  III  Corp.  intend  to  request  a name  change  to
Integrated  Medical  Solutions Inc. to better reflect the acquired  business and
general business model.

THE "ACQUIRED" BUSINESS

Founded in 1989,  Integrated Medical Solutions,  Inc. (otherwise known as "IMS")
is a provider of technology-based  solutions to the health care industry. IMS is
in the business of developing and  implementing  asset  management  systems that
enable healthcare companies and organizations to improve  productivity,  deliver
better  customer  service and provide  more  effective  security.  IMS  designs,
develops and markets  proprietary  radio  frequency  (RFID) devices and software
solutions  that make it possible to access,  manage,  and control any asset in a
medical  operation.  IMS has developed  solutions to locate equipment and manage
assets,  to minimize  patient wait times, and to streamline the flow of patients
through a  facility  or  clinic.  The  Company's  solutions,  which  consist  of
software,  services and hardware,  can integrate the supply chain  constituents,
including  manufacturers,   distributors,  medical  facilities,   transportation
providers, staff and patients.

As the core  technology  in its  solutions,  proprietary  radio  frequency  (RF)
technology automatically identifies the precise real-time location of people and
equipment  moving  within a medical  facility.  IMS designs and supports a broad
range of tags, readers, scanners and software for radio frequency identification
(RFID) systems used in automatic  identification,  data  collection and personal
identification  applications.  The RFID technology is used with products such as
networking routers,  medical instruments,  bar code scanners,  security cameras,
card  readers,  time  clocks,  and  virtually  any product that has some form of
standard  data control  capability.  Applications  are most common in areas that
require  high  levels of data  accuracy  and where  speed  and  reliability  are
critical.  Applications for IMS' technology include inventory control, equipment
management,  JIT (Just-In-Time) ordering,  employee time and attendance records,
people tracking, file management systems,  hospital information systems, medical
specimen  labeling,  and  access  control  systems.  The data  collected  is fed
real-time into application software used by each department (finance,  security,
operations, biomed, maintenance, purchasing) to improve their analysis and asset
utilization.

IMS'  target  market  segments  include,  but are not  limited  to,  acute  care
hospitals,  hospices,  medical centers,  medical labs, nursing homes, retirement
communities  & homes,  cancer  centers,  emergency  surgery and trauma  centers,
women's health centers,  inpatient units, bed towers,  medical office buildings,
ambulatory care facilities, cardiac facilities,  pediatric facilities, radiology
centers,  research  and  teaching  hospitals,   medical  universities,   medical
colleges,  medical technical schools, kidney dialysis facilities,  mental health
inpatient  facilities,   transplant  centers,   reproductive  medicine  clinics,
prisons, jails, correctional facilities and other related healthcare facilities.

IMS is  headquartered  in Atlanta,  Georgia  and has offices in Houston,  Texas;
Chicago,  Illinois;  and Cypress,  California.  It has partnerships with leading
healthcare construction companies Jacobs Engineering and Turner Construction and

<PAGE>

supplier  agreements with numerous  healthcare  Group  Purchasing  Organizations
(GPOs)  such as Premier,  Novation,  Amerinet,  MedAssets,  and MHA. It has also
signed a purchasing  agreement to purchase  from 250  healthcare  equipment  and
supplies  manufacturers  encompassing over 30,000 products. It seeks to leverage
these relationship and 15 years of experience in the healthcare industry through
the implementation of its RFID-based products.

PRODUCTS AND SERVICES

As the core  technology  in its  solutions,  proprietary  radio  frequency  (RF)
technology automatically identifies the precise real-time location of people and
equipment  moving  within a medical  facility.  IMS designs and supports a broad
range of tags, readers, scanners and software for radio frequency identification
(RFID) systems used in automatic  identification,  data  collection and personal
identification  applications.  The RFID technology is used with products such as
networking routers,  medical instruments,  bar code scanners,  security cameras,
card  readers,  time  clocks,  and  virtually  any product that has some form of
standard  data control  capability.  Applications  are most common in areas that
require  high  levels of data  accuracy  and where  speed  and  reliability  are
critical.  Applications for IMS' technology include inventory control, equipment
management,  JIT (Just-In-Time) ordering,  employee time and attendance records,
people tracking, file management systems,  hospital information systems, medical
specimen  labeling,  and  access  control  systems.  The data  collected  is fed
real-time into application software used by each department (finance,  security,
operations, biomed, maintenance, purchasing) to improve their analysis and asset
utilization.

IMS has  proprietary  products  and  consulting  expertise  that  allow  medical
facility operators to better manage major assets (equipment, staff, patients and
inventory).   Given  increased  government  regulations  and  medical  insurance
requirements,  these  operators  are under  pressure to reduce costs and improve
productivity.  IMS has a long  history  of  marketing  to  these  operators  and
understands  that  the  emerging  RFID  technology  is the core  technology  for
improving the operation of medical facilities by providing real-time information
and by integrating the numerous  systems and  applications.  The marketing of an
RFID system is easiest at the time of construction and through  healthcare group
purchasing   organizations   (GPOs),  which  are  increasingly   dominating  the
purchasing process for these operators.  IMS has signed  partnership  agreements
with leading  healthcare  construction  companies  like Jacobs  Engineering  and
Turner Construction, along with leading GPOs such as Premier and Novation.

With an innovative  product and  partnerships  with  well-established  companies
providing  entry  into the  purchasing  process,  IMS  believes  it can secure a
significant share of the market for asset management  technology and application
software. However, the IMS business model goes further and realizes that once it
implements a system in a facility and provides annual support,  it has access to
the  purchasing  needs of that  facility.  As a result,  the  Company has signed
purchasing  agreements  to procure from over 250  manufacturers,  totaling  over
30,000  medical  products.  IMS  believes  it can  become  a major  supplier  of
equipment  and  accessories  to the  healthcare  industry  by  having  access to
inventory levels and asset history.

RFID VALUE PROPOSITION TO HEALTHCARE INDUSTRY

RFID has caught the world and investors  attention  because of its planned usage
by such  big  spenders  as  Wal-Mart,  the  world's  biggest  retailer,  and the
Department of Defense, with an annual budget of $400 billion, and Delta Airlines
spending  $25  million to reduce  present  costs of $100  million  for  tracking
luggage.  According to Forrester Research, RFID is among the top trends to watch
in 2004 after  interviewing  more than 500 IT  managers  to compile  its list of
prognostications  for the  upcoming  year.  Investors  should  expect  the  RFID
landscape  to evolve  rapidly and  extensively  as the  technology  becomes more
standardized  and it  becomes  clearer  how it can be best  applied.  The use of
radio-frequency  identification  in  healthcare  is a new  use  of  an  existing
technology.

The U.S. healthcare market is a $1.4 trillion industry that is projected to grow
to $2.6  trillion by 2010,  according  to the Centers for  Medicare and Medicaid
Services.  With this enormous  growth comes the need for new  technologies,  for
enhanced information exchange that can streamline the way business is conducted,
save lives and improve the quality of life for  patients.  I.T. is the  backbone
upon which healthcare's future will be built. Currently,  healthcare information
technology  represents a $33 billion a year market. Yet, healthcare continues to

<PAGE>

lag behind other business  sectors for I.T.  spending.  However,  a long list of
factors,  including  strong  pressure to prevent medical errors plus the need to
comply with  regulations,  including HIPAA, are combining to spur serious growth
in I.T. spending.

The healthcare  industry is at a crossroads.  Advances in new medical technology
are providing the United States with the best  healthcare  products and services
in the  world.  At the same time,  healthcare  organizations  are under  intense
pressure to cut costs from every  corner.  There are  staggering  reductions  in
government-based  reimbursement,  managed care payment caps, staffing shortages,
increases in regulations including the implementation of HIPAA and the growth in
demand for added  services  fueled by the aging of the  baby-boomer  generation.
Patient care itself is at significant  risk.  There are several trends that will
drive the healthcare industry to adopt the RFID technology rapidly.

 1. SHRINKING HEALTHCARE BUDGETS: Healthcare is more than ever a revenue-focused
    environment.  Hospitals must act like businesses and be run like businesses.
    RF tracking solutions affect the bottom line in several ways:

o REDUCED THEFT.  Placing RF tags on portable  equipment helps prevent theft. By
alarming or notifying  security of a potential  problem,  fewer wheelchairs will
end up in the trunks of patient cars, and more money will remain in the hospital
coffers for value-added investment.

o DECREASED RENTALS.  Because equipment will no longer be "hidden" by frustrated
clinicians  or  lost  and  underutilized,  rental  requirements  will  drop  and
equipment utilization should rise with the use of RFID.

2. DECREASED  STAFFING  LEVELS:  The U.S. is facing a  nursing-shortage  crisis.
According to Hospital  Today,  it is projected  that by 2020 there will be a 20%
shortage of nurses for a total deficit of 400,000 nurses nationwide.  Clinicians
cannot afford to spend time looking for the equipment or people they need:

o STAFF EFFICIENCY.  RF tracking solutions put access to equipment location at a
clinician's   fingertips.   This  not  only  drives  up  productivity   and  job
satisfaction,  but also  reduces  hoarding  of  equipment  by nurses  who do not
believe  that there is any  alternative  if they want to quickly  access  needed
equipment.  Clinicians can locate patients and reduce wasted time calling around
or searching for where a patient has been transported.

3.  INCREASED  HOSPITAL  ADMISSIONS:  Hospital  admissions  are on the  rise  as
baby-boomers  age. The number of "seniors"  over 65 years of age will soon equal
nearly half of the total population in the United States.  This aging population
is creating increased healthcare demands.  Technology is expected to be critical
in helping hospitals process the increase in demand.

The challenges impacting healthcare are some of the most complex and troublesome
in history. As a result,  hospitals and health facilities realize they must find
new ways to lower expenses in other areas. After years of neglect, more hospital
and  Integrated  Delivery  Network  (IDN)  CEOs are  paying  attention  to their
second-largest  business operations  expenses--supply  chain  management--as one
place where they actually can impact costs.  It has been well documented for the
past several years that 30 percent of all dollars spent in healthcare supply and
equipment purchasing is wasted, because of inefficiencies, and that at least $11
billion of cost savings could be squeezed out.

 The U.S.  Department of Commerce  estimates  that roughly $300 billion worth of
medical supplies,  services,  and  pharmaceuticals are bought globally each year
through the medical  technology supply chain. The healthcare supply chain system
has tremendous  potential to decrease overall  healthcare costs. The most recent
survey  estimates that hospitals  could save $11 billion a year in supply costs,
but that likely is much higher  today.  Thus,  the  strategic  value that supply
chain management can bring to healthcare organizations is critical.

Equipment  management is a universal problem.  It affects just about every facet
of the hospital,  from the loading dock to the surgical  suite.  There literally
are  thousands  of pieces of  mobile  medical  equipment  that move  around  the
hospital  each day with a specific  business  process and  workflow  attached to

<PAGE>

them.  IMS has solutions to improve  medical asset  utilization.  Thus,  the key
factors  influencing  demand for IMS'  products  are the  increase  in  patients
needing care, the hospital's  needs to save money without  compromising  patient
care and medical supply and equipment usage statistics.  In all cases the trends
are  upwards in favor of IMS'  Asset  Management  Systems  with the use of Radio
Frequency Identification (RFID) technology growing rapidly.

SECTION 8 - OTHER EVENTS

ITEM 8.01 OTHER EVENTS.

The Company is currently  negotiating financing in the form of a bridge loan for
a total of $500,000 and is planning a private  placement  financing on or before
October 31, 2005 for  approximately  USD$5,500,000 to a maximum of USD$7,500,000
in order to expand into other regions and launch new products and services.


ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.


(a) Financial statements of business acquired.


The financial  statements  required by this Item 9(a) will be filed by amendment
to the Form 8-K filed with the Securities  and Exchange  Commission on March 28,
2005, within the period permitted by Item 9(a)(4) of Form 8-K.


(b) Pro Forma financial information

The pro forma financial  information required by this Item 9(b) will be filed by
amendment to the Form 8-K filed with the Securities  and Exchange  Commission on
March 28, 2005, within the period permitted by Item 9(a)(4) of Form 8-K.

(c)  Exhibits

         Exhibits          Description
         --------          -----------

         2.1               Agreement  and Plan of  Merger by and  between  Ideal
                           Medical Inc, OSK  Acquisition  Corp.  and OSK Capital
                           III,  Corp.,  dated March 14, 2005  (incorporated  by
                           reference  to the Form 8-K filed with the  Securities
                           and Exchange Commission on March 28, 2005).

<PAGE>

                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                              OSK CAPITAL III CORP.



DATE: April 14, 2005                          /s/ Francis Mailhot
                                              ------------------------
                                              Francis Mailhot
                                              Director
                                              OSK CAPITAL III CORP.
{"company-data": {"conformed-name": "OSK CAPITAL III CORP", "cik": "0001107565", "assigned-sic": "9995", "irs-number": "841491676", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-30023", "film-number": "05751040"}, "business-address": {"street1": "4750 TABLE MESA DR", "city": "BOULDER", "state": "CO", "zip": "80303", "phone": "3034943000"}, "mail-address": {"street1": "4750 TABLE MESA DR", "city": "BOULDER", "state": "CO", "zip": "80303"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

                         Date of Report: April 14, 2005
                        --------------------------------
                        (Date of earliest event reported)

                              OSK CAPITAL III CORP.
                      ------------------------------------
             (Exact name of registrant as specified in its charter)

        COLORADO                  000-30023                     84-1491676
    --------------               -----------             ---------------------
        State of                 Commission                   IRS Employer
     incorporation               File Number             Identification Number

                               1 Place Ville-Marie
                                   Suite 2821
                                  Montreal, Qc
                                     H3B 4R4
             -------------------------------------------------------
                    (Address of principal executive offices)

                                Tel: 514-448-6710
                              --------------------
                           (Issuer's telephone number)

                      P. O. Box 461029, Glendale, CO 80220
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

Copies of all communications, including all communications sent to the agent for
service

Copies of all communications, including all communications sent to the agent for
service, should be sent to:

                              Joseph I. Emas, Esq.
                                 Attorney at Law
                             1224 Washington Avenue
                              Miami Beach, FL 33139
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS

ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.

The Company was  incorporated  under the laws of the State of Nevada on March 2,
1999, and is in the early  developmental  and promotional  stages.  To date, the
Company's only activities have been organizational  ones, directed at developing
its business plan and raising its initial capital. The Company has not commenced
any commercial operations.

On March 15, 2004, Frank Kramer and Deborah Salerno have resigned as officers of
OSK  CAPITAL  III  CORP.  and have  also  resigned  as  members  of the Board of
Directors of OSK CAPITAL III CORP. Further to the resignation of Ms. Salerno and
Mr. Kramer,  Francis Mailhot remains the sole director and has been nominated as
President and CEO of the Company.

On March 14, 2005, OSK CAPITAL III ("OSC"), a Nevada corporation,  completed the
acquisition of Ideal Medical Inc., a Texas corporation, pursuant to an Agreement
and Plan of Merger,  the form of which is attached as Exhibit 2.1 hereto whereby
OSC to exchanged shares of OSC for one hundred percent (100%) of the outstanding
shares of Ideal Medical,  Inc. d/b/a Integrated  Medical  Solutions  ("IMS"),  a
Texas corporation.  At the effective time of the merger,  Ideal Medical Inc. was
merged with and into our wholly  owned  subsidiary,  OSK  Acquisition  Corp.,  a
Florida  corporation,  which will be subsequently  dissolved and merged into the
Company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

Management of OSK Capital III Corp.  intend to request a name change  Integrated
Medical  Solutions  Inc. to better  reflect the  acquired  business  and general
business model.

SECTION 2 - FINANCIAL INFORMATION

ITEM 2.01 COMPLETION OF ACQUISITION OR DISPOSITION OF ASSETS.

On March 14, 2005, the company  completed the acquisition of Ideal Medical Inc.,
a Texas  corporation,  pursuant to an Agreement and Plan of Merger,  the form of
which is attached as Exhibit 2.1 hereto.  At the  effective  time of the merger,
Ideal Medical Inc. will be merged with and into our wholly owned subsidiary, OSK
Acquisition Corp., a Florida corporation,  which will be subsequently  dissolved
and merged into the company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT

ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT.

Pursuant to the completion of the reverse merger  transaction on March 30, 2005,
a change  of  control  occurred.  The  table  below  outlines  the  shareholders
representing Officers,  Directors,  Control and or Affiliates and the percentage
owned by them post reverse merger.
---------------------------------------------------- ------------------- --------------
        NAME OF SHAREHOLDER                                   NUMBER OF SHARES     PERCENTAGE
                                                                   OWNED
        ---------------------------------------------------- ------------------- --------------
Angela Buffa (1)                                         16,000,000           67.5%
        ---------------------------------------------------- ------------------- --------------
        Mawe Investments  (2)                                    4,000,000            16.9%
        ---------------------------------------------------- ------------------- --------------
        Les Services Financiers Francis Mailhot Inc. (3)          268,668              1%
        ---------------------------------------------------- ------------------- --------------
        Toyma Capital Inc. (4)                                    394,918              2%
        ---------------------------------------------------- ------------------- --------------
        9088-0909 Quebec Inc. (5)                                  73,250             0.03%
        ---------------------------------------------------- ------------------- --------------
        Marie-France Giguere (6)                                   30,000             0.01%
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES HELD BY DIRECTORS, OFFICER, CONTROL         20,766,836            88%
        AND OR AFFILIATES
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES HELD BY PUBLIC (7)                          2,933,164             12%
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES OUTSTANDING (8)                             23,700,000           100%
        ---------------------------------------------------- ------------------- --------------
        Warrants (9)                                                 0
        ---------------------------------------------------- ------------------- --------------
        Options (10)                                               80,000
        ---------------------------------------------------- ------------------- --------------
        TOTAL SHARES OUTSTANDING ON A FULLY DILUTED BASIS        23,780,000
        ---------------------------------------------------- ------------------- --------------
1)       Angela Buffa is the Issuer's  Chairman and Chief  Executive  Officer
2)       Mawe Investments is a company 100% owned and controlled by Louisa Santo
3)       Les Services  Financiers  Francis  Mailhot Inc. Is a company 100% owned
         and controlled by Francis  Mailhot and Francis Mailhot is a director of
         the issuer and is a managing  director at Finkelstein  Capital Inc. and
         Finkelstein Capital Inc. is a corporate finance advisory firm presently
         retained by the Issuer.  Les Services  Financiers  Francis Mailhot Inc.
         owns 25% of Finkelstein Capital Inc.
4)       Toyma Capital Inc. is a company 100% owned by the Amyot Family Trust of
         which Mr.  Jean-Francois Amyot is one of the beneficiaries of the trust
         and Mr. Amyot is a managing  director of  Finkelstein  Capital Inc. and
         Finkelstein Capital Inc. is a corporate finance advisory firm presently
         retained by the Issuer.  Toyma  Capital  Inc.  owns 25% of  Finkelstein
         Capital Inc.
5)       9088-0909  Quebec Inc. is a company 100% owned by Marie-France  Giguere
         who is the common law spouse of Francis  Mailhot,  one of the  Issuer's
         Director.
6)       Marie-France  Giguere is the common law spouse of Francis Mailhot,  one
         of the Issuer's Director.
7)       There  are  2,933,164  held  by the  public,  of  which  1,102,000  are
         registered and 1,831,164 are restricted.
8)       There are total of 23,700,000 shares  outstanding held by a total of 64
         shareholders.
9)       No warrants have been issued
10)      In 2004, Roger Morlan received 30,000 options  exercisable on or before
         January 2, 2007 at a strike price of $0.50,  also in 2004, Myra Batista
         received  20,000 options  exercisable on or before January 2, 2007 at a
         strike price of $0.50,  In 2003,  Roger Morlan  received 20,000 options
         exercisable  on or before  January 2, 2006 at a strike  price of $0.30,
         also in 2003, Myra Batista  received  10,000 options  exercisable on or
         before January 2, 2006 at a strike price of $0.30.
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL  OFFICERS;  ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.

Pursuant  to  the  reverse  merger  transaction,   the  following  Election  and
nomination took place on March 30, 2005.

ANGELA BUFFA, Chairman, President

Angela  Buffa has been the  Chairman of the Board  since  1989.  She founded the
Company as a diagnostic imaging equipment and commodities supplier after serving
as a  national  sales  manager  and  general  manager  for two major  healthcare
companies.  As the Chief Executive  Officer,  she has directed and  administered
hundreds of healthcare,  construction and government projects across the country
during the last sixteen years. Under her leadership, Ideal Medical Systems, Inc.
was the  recipient in 2001 of the  "Emerging  Top Ten  Businesses"  award by the
Houston  Business  Council.  During the last two years,  Ms. Buffa has developed
innovative  proprietary  RFID  technologies  that  bring  new  solutions  to the
healthcare industry's challenges.  She has business training from Dartmouth Amos
Tuck School of Business  Administration,  University of Texas Advanced Executive
Program,  and Clark  University.  She has also served as moderator  and industry
expert at numerous  healthcare  conferences  and small business  venture capital
seminars.

ROGER MORLAN, Director

Roger W. Morlan has been a director since August 1999.  Since February 1993, Mr.
Morlan has been the Chief Executive Officer of Cobb Real Estate Construction and
Development,  Inc. based in Atlanta, Georgia. Prior to starting Cobb, Mr. Morlan
was a Project Manager for Senco  Products,  Inc., a major  manufacturer  for the
construction  industry,  a firm  which he  joined in 2002.  Prior to Senco,  Mr.
Morlan was the  Director  of  Marketing  for Ideal  Medical,  Inc.  where he was
responsible  for  establishing   relationships  with  leading  Group  Purchasing
Organizations  (GPOs).  Mr. Morlan has a B.A. in International  Economic Affairs
with a minor in Management from the State University of West Georgia.

MYRA BATISTA, Director

Myra Batista has been a director since January 2001.  From 1998, Ms. Batista has
been the Manager of  Occupational  Therapy at  Palmetto  General  Hospital  with
responsibilities  that include managing the durable medical equipment program at
one of the largest  hospitals in Florida.  Ms.  Batista has been a consultant to
various  companies  with a focus on managing and  maximizing  the usage of their
medical  equipment  inventory.  Ms.  Batista has a B.S.  degree in  Occupational
Therapy from Florida  International  University with certifications on Automated
External Defibrillator and on Ultrasound Equipment.

ITEM 7.01 REGULATION FD DISCLOSURE.

The Company was  incorporated  under the laws of the State of Nevada on March 2,
1999, and is in the early  developmental  and promotional  stages.  To date, the
Company's only activities have been organizational  ones, directed at developing
its business plan and raising its initial capital. The Company has not commenced
any commercial operations.

On March 15, 2004, Frank Kramer and Deborah Salerno have resigned as officers of
OSK  CAPITAL  III  CORP.  and have  also  resigned  as  members  of the Board of
Directors of OSK CAPITAL III CORP. Further to the resignation of Ms. Salerno and
Mr. Kramer,  Francis Mailhot remains the sole director and has been nominated as
President and CEO of the Company.

On March 14, 2005, OSK CAPITAL III ("OSC"), a Nevada corporation,  completed the
acquisition of Ideal Medical Inc., a Texas corporation, pursuant to an Agreement
and Plan of Merger,  the form of which is attached as Exhibit 2.1 hereto whereby
OSC to exchanged shares of OSC for one hundred percent (100%) of the outstanding
shares of Ideal Medical,  Inc. d/b/a Integrated  Medical  Solutions  ("IMS"),  a
Texas corporation.  At the effective time of the merger,  Ideal Medical Inc. was
merged with and into our wholly  owned  subsidiary,  OSK  Acquisition  Corp.,  a
Florida  corporation,  which will be subsequently  dissolved and merged into the
Company.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

Management  of OSK  Capital  III  Corp.  intend  to  request  a name  change  to
Integrated  Medical  Solutions Inc. to better reflect the acquired  business and
general business model.

THE "ACQUIRED" BUSINESS

Founded in 1989,  Integrated Medical Solutions,  Inc. (otherwise known as "IMS")
is a provider of technology-based  solutions to the health care industry. IMS is
in the business of developing and  implementing  asset  management  systems that
enable healthcare companies and organizations to improve  productivity,  deliver
better  customer  service and provide  more  effective  security.  IMS  designs,
develops and markets  proprietary  radio  frequency  (RFID) devices and software
solutions  that make it possible to access,  manage,  and control any asset in a
medical  operation.  IMS has developed  solutions to locate equipment and manage
assets,  to minimize  patient wait times, and to streamline the flow of patients
through a  facility  or  clinic.  The  Company's  solutions,  which  consist  of
software,  services and hardware,  can integrate the supply chain  constituents,
including  manufacturers,   distributors,  medical  facilities,   transportation
providers, staff and patients.

As the core  technology  in its  solutions,  proprietary  radio  frequency  (RF)
technology automatically identifies the precise real-time location of people and
equipment  moving  within a medical  facility.  IMS designs and supports a broad
range of tags, readers, scanners and software for radio frequency identification
(RFID) systems used in automatic  identification,  data  collection and personal
identification  applications.  The RFID technology is used with products such as
networking routers,  medical instruments,  bar code scanners,  security cameras,
card  readers,  time  clocks,  and  virtually  any product that has some form of
standard  data control  capability.  Applications  are most common in areas that
require  high  levels of data  accuracy  and where  speed  and  reliability  are
critical.  Applications for IMS' technology include inventory control, equipment
management,  JIT (Just-In-Time) ordering,  employee time and attendance records,
people tracking, file management systems,  hospital information systems, medical
specimen  labeling,  and  access  control  systems.  The data  collected  is fed
real-time into application software used by each department (finance,  security,
operations, biomed, maintenance, purchasing) to improve their analysis and asset
utilization.

IMS'  target  market  segments  include,  but are not  limited  to,  acute  care
hospitals,  hospices,  medical centers,  medical labs, nursing homes, retirement
communities  & homes,  cancer  centers,  emergency  surgery and trauma  centers,
women's health centers,  inpatient units, bed towers,  medical office buildings,
ambulatory care facilities, cardiac facilities,  pediatric facilities, radiology
centers,  research  and  teaching  hospitals,   medical  universities,   medical
colleges,  medical technical schools, kidney dialysis facilities,  mental health
inpatient  facilities,   transplant  centers,   reproductive  medicine  clinics,
prisons, jails, correctional facilities and other related healthcare facilities.

IMS is  headquartered  in Atlanta,  Georgia  and has offices in Houston,  Texas;
Chicago,  Illinois;  and Cypress,  California.  It has partnerships with leading
healthcare construction companies Jacobs Engineering and Turner Construction and
supplier  agreements with numerous  healthcare  Group  Purchasing  Organizations
(GPOs)  such as Premier,  Novation,  Amerinet,  MedAssets,  and MHA. It has also
signed a purchasing  agreement to purchase  from 250  healthcare  equipment  and
supplies  manufacturers  encompassing over 30,000 products. It seeks to leverage
these relationship and 15 years of experience in the healthcare industry through
the implementation of its RFID-based products.

PRODUCTS AND SERVICES

As the core  technology  in its  solutions,  proprietary  radio  frequency  (RF)
technology automatically identifies the precise real-time location of people and
equipment  moving  within a medical  facility.  IMS designs and supports a broad
range of tags, readers, scanners and software for radio frequency identification
(RFID) systems used in automatic  identification,  data  collection and personal
identification  applications.  The RFID technology is used with products such as
networking routers,  medical instruments,  bar code scanners,  security cameras,
card  readers,  time  clocks,  and  virtually  any product that has some form of
standard  data control  capability.  Applications  are most common in areas that
require  high  levels of data  accuracy  and where  speed  and  reliability  are
critical.  Applications for IMS' technology include inventory control, equipment
management,  JIT (Just-In-Time) ordering,  employee time and attendance records,
people tracking, file management systems,  hospital information systems, medical
specimen  labeling,  and  access  control  systems.  The data  collected  is fed
real-time into application software used by each department (finance,  security,
operations, biomed, maintenance, purchasing) to improve their analysis and asset
utilization.

IMS has  proprietary  products  and  consulting  expertise  that  allow  medical
facility operators to better manage major assets (equipment, staff, patients and
inventory).   Given  increased  government  regulations  and  medical  insurance
requirements,  these  operators  are under  pressure to reduce costs and improve
productivity.  IMS has a long  history  of  marketing  to  these  operators  and
understands  that  the  emerging  RFID  technology  is the core  technology  for
improving the operation of medical facilities by providing real-time information
and by integrating the numerous  systems and  applications.  The marketing of an
RFID system is easiest at the time of construction and through  healthcare group
purchasing   organizations   (GPOs),  which  are  increasingly   dominating  the
purchasing process for these operators.  IMS has signed  partnership  agreements
with leading  healthcare  construction  companies  like Jacobs  Engineering  and
Turner Construction, along with leading GPOs such as Premier and Novation.

With an innovative  product and  partnerships  with  well-established  companies
providing  entry  into the  purchasing  process,  IMS  believes  it can secure a
significant share of the market for asset management  technology and application
software. However, the IMS business model goes further and realizes that once it
implements a system in a facility and provides annual support,  it has access to
the  purchasing  needs of that  facility.  As a result,  the  Company has signed
purchasing  agreements  to procure from over 250  manufacturers,  totaling  over
30,000  medical  products.  IMS  believes  it can  become  a major  supplier  of
equipment  and  accessories  to the  healthcare  industry  by  having  access to
inventory levels and asset history.

RFID VALUE PROPOSITION TO HEALTHCARE INDUSTRY

RFID has caught the world and investors  attention  because of its planned usage
by such  big  spenders  as  Wal-Mart,  the  world's  biggest  retailer,  and the
Department of Defense, with an annual budget of $400 billion, and Delta Airlines
spending  $25  million to reduce  present  costs of $100  million  for  tracking
luggage.  According to Forrester Research, RFID is among the top trends to watch
in 2004 after  interviewing  more than 500 IT  managers  to compile  its list of
prognostications  for the  upcoming  year.  Investors  should  expect  the  RFID
landscape  to evolve  rapidly and  extensively  as the  technology  becomes more
standardized  and it  becomes  clearer  how it can be best  applied.  The use of
radio-frequency  identification  in  healthcare  is a new  use  of  an  existing
technology.

The U.S. healthcare market is a $1.4 trillion industry that is projected to grow
to $2.6  trillion by 2010,  according  to the Centers for  Medicare and Medicaid
Services.  With this enormous  growth comes the need for new  technologies,  for
enhanced information exchange that can streamline the way business is conducted,
save lives and improve the quality of life for  patients.  I.T. is the  backbone
upon which healthcare's future will be built. Currently,  healthcare information
technology  represents a $33 billion a year market. Yet, healthcare continues to
lag behind other business  sectors for I.T.  spending.  However,  a long list of
factors,  including  strong  pressure to prevent medical errors plus the need to
comply with  regulations,  including HIPAA, are combining to spur serious growth
in I.T. spending.

The healthcare  industry is at a crossroads.  Advances in new medical technology
are providing the United States with the best  healthcare  products and services
in the  world.  At the same time,  healthcare  organizations  are under  intense
pressure to cut costs from every  corner.  There are  staggering  reductions  in
government-based  reimbursement,  managed care payment caps, staffing shortages,
increases in regulations including the implementation of HIPAA and the growth in
demand for added  services  fueled by the aging of the  baby-boomer  generation.
Patient care itself is at significant  risk.  There are several trends that will
drive the healthcare industry to adopt the RFID technology rapidly.

 1. SHRINKING HEALTHCARE BUDGETS: Healthcare is more than ever a revenue-focused
    environment.  Hospitals must act like businesses and be run like businesses.
    RF tracking solutions affect the bottom line in several ways:

o REDUCED THEFT.  Placing RF tags on portable  equipment helps prevent theft. By
alarming or notifying  security of a potential  problem,  fewer wheelchairs will
end up in the trunks of patient cars, and more money will remain in the hospital
coffers for value-added investment.

o DECREASED RENTALS.  Because equipment will no longer be "hidden" by frustrated
clinicians  or  lost  and  underutilized,  rental  requirements  will  drop  and
equipment utilization should rise with the use of RFID.

2. DECREASED  STAFFING  LEVELS:  The U.S. is facing a  nursing-shortage  crisis.
According to Hospital  Today,  it is projected  that by 2020 there will be a 20%
shortage of nurses for a total deficit of 400,000 nurses nationwide.  Clinicians
cannot afford to spend time looking for the equipment or people they need:

o STAFF EFFICIENCY.  RF tracking solutions put access to equipment location at a
clinician's   fingertips.   This  not  only  drives  up  productivity   and  job
satisfaction,  but also  reduces  hoarding  of  equipment  by nurses  who do not
believe  that there is any  alternative  if they want to quickly  access  needed
equipment.  Clinicians can locate patients and reduce wasted time calling around
or searching for where a patient has been transported.

3.  INCREASED  HOSPITAL  ADMISSIONS:  Hospital  admissions  are on the  rise  as
baby-boomers  age. The number of "seniors"  over 65 years of age will soon equal
nearly half of the total population in the United States.  This aging population
is creating increased healthcare demands.  Technology is expected to be critical
in helping hospitals process the increase in demand.

The challenges impacting healthcare are some of the most complex and troublesome
in history. As a result,  hospitals and health facilities realize they must find
new ways to lower expenses in other areas. After years of neglect, more hospital
and  Integrated  Delivery  Network  (IDN)  CEOs are  paying  attention  to their
second-largest  business operations  expenses--supply  chain  management--as one
place where they actually can impact costs.  It has been well documented for the
past several years that 30 percent of all dollars spent in healthcare supply and
equipment purchasing is wasted, because of inefficiencies, and that at least $11
billion of cost savings could be squeezed out.

 The U.S.  Department of Commerce  estimates  that roughly $300 billion worth of
medical supplies,  services,  and  pharmaceuticals are bought globally each year
through the medical  technology supply chain. The healthcare supply chain system
has tremendous  potential to decrease overall  healthcare costs. The most recent
survey  estimates that hospitals  could save $11 billion a year in supply costs,
but that likely is much higher  today.  Thus,  the  strategic  value that supply
chain management can bring to healthcare organizations is critical.

Equipment  management is a universal problem.  It affects just about every facet
of the hospital,  from the loading dock to the surgical  suite.  There literally
are  thousands  of pieces of  mobile  medical  equipment  that move  around  the
hospital  each day with a specific  business  process and  workflow  attached to
them.  IMS has solutions to improve  medical asset  utilization.  Thus,  the key
factors  influencing  demand for IMS'  products  are the  increase  in  patients
needing care, the hospital's  needs to save money without  compromising  patient
care and medical supply and equipment usage statistics.  In all cases the trends
are  upwards in favor of IMS'  Asset  Management  Systems  with the use of Radio
Frequency Identification (RFID) technology growing rapidly.

SECTION 8 - OTHER EVENTS

ITEM 8.01 OTHER EVENTS.

The Company is currently  negotiating financing in the form of a bridge loan for
a total of $500,000 and is planning a private  placement  financing on or before
October 31, 2005 for  approximately  USD$5,500,000 to a maximum of USD$7,500,000
in order to expand into other regions and launch new products and services.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(a) Financial statements of business acquired.

The financial  statements  required by this Item 9(a) will be filed by amendment
to the Form 8-K filed with the Securities  and Exchange  Commission on March 28,
2005, within the period permitted by Item 9(a)(4) of Form 8-K.

(b) Pro Forma financial information

The pro forma financial  information required by this Item 9(b) will be filed by
amendment to the Form 8-K filed with the Securities  and Exchange  Commission on
March 28, 2005, within the period permitted by Item 9(a)(4) of Form 8-K.

(c)  Exhibits

         Exhibits          Description
         --------          -----------

         2.1               Agreement  and Plan of  Merger by and  between  Ideal
                           Medical Inc, OSK  Acquisition  Corp.  and OSK Capital
                           III,  Corp.,  dated March 14, 2005  (incorporated  by
                           reference  to the Form 8-K filed with the  Securities
                           and Exchange Commission on March 28, 2005).
SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                              OSK CAPITAL III CORP.

DATE: April 14, 2005                          /s/ Francis Mailhot
                                              ------------------------
                                              Francis Mailhot
                                              Director
                                              OSK CAPITAL III CORP.